Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Operating Leases (2023 - 2025)

Historic Operating Leases for CG Oncology (CGON) over the last 3 years, with Q3 2025 value amounting to $3.3 million.

  • CG Oncology's Operating Leases rose 458873.24% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 million, marking a year-over-year increase of 458873.24%. This contributed to the annual value of $52000.0 for FY2024, which is 7868.85% down from last year.
  • Latest data reveals that CG Oncology reported Operating Leases of $3.3 million as of Q3 2025, which was up 458873.24% from $706000.0 recorded in Q2 2025.
  • In the past 5 years, CG Oncology's Operating Leases registered a high of $3.3 million during Q3 2025, and its lowest value of $52000.0 during Q4 2024.
  • Its 3-year average for Operating Leases is $685625.0, with a median of $214000.0 in 2023.
  • As far as peak fluctuations go, CG Oncology's Operating Leases tumbled by 7868.85% in 2024, and later skyrocketed by 458873.24% in 2025.
  • CG Oncology's Operating Leases (Quarter) stood at $244000.0 in 2023, then tumbled by 78.69% to $52000.0 in 2024, then soared by 6301.92% to $3.3 million in 2025.
  • Its Operating Leases was $3.3 million in Q3 2025, compared to $706000.0 in Q2 2025 and $781000.0 in Q1 2025.